🇺🇸 FDA

Intelligence Platform

Patents

Browse 4 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7579333

Therapy using a combination of raloxifene and alendronate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6696601

Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6476006

Composition and dosage form for delayed gastric release of alendronate and/or other bis-ph

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6281381

Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired